Back to Search

JACLYN JAKUBOWSKI, MD STUDENT

MD STUDENT

Student in an Organized Health Care Education/Training Program

NPI: 1366256992Individual

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training ProgramPrimary

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Research & Publications (20)

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
PMID 19435740·Eur Heart J·2009
4-observational
Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12 receptor when interacting with antagonists.
PMID 18983481·J Thromb Haemost·2009
8-other
Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseases.
PMID 19356727·Eur J Pharmacol·2009
7-preclinical
Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects.
PMID 19637095·Platelets·2009
4-observational
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin.
PMID 19249429·Am Heart J·2009
4-observational
The use of corticosteroids and nonsteroidal antiinflammatory medication for the management of pain and inflammation after third molar surgery: a review of the literature.
PMID 19157919·Oral Surg Oral Med Oral Pathol Oral Radiol Endod·2009
6-review
Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects.
PMID 19530977·Curr Med Res Opin·2009
3-trial
The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function.
PMID 18485086·J Thromb Haemost·2008
8-other
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects.
PMID 18569863·Platelets·2008
2-rct
Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor.
PMID 18752581·J Thromb Haemost·2008
7-preclinical
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.
PMID 18841285·Thromb Haemost·2008
4-observational
Linear discriminant analysis of MUAP scalograms.
PMID 19162855·Annu Int Conf IEEE Eng Med Biol Soc·2008
8-other
Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.
PMID 19025429·Pharmacotherapy·2008
2-rct
The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
PMID 18297550·Platelets·2008
8-other
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration.
PMID 18278193·Thromb Haemost·2008
4-observational
Activated protein C modulates chemokine response and tissue injury in experimental sepsis.
PMID 18290317·Adv Exp Med Biol·2008
4-observational
Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo.
PMID 19055987·J Am Coll Cardiol·2008
4-observational
A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
PMID 18217157·Thromb Haemost·2008
4-observational
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease.
PMID 18055486·Eur Heart J·2008
4-observational
The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities.
PMID 18021304·J Thromb Haemost·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
URB. TURABO GARDENS CARR. #172 CAGUAS A CIDRA
CAGUAS, PR 00725

Location

Practice Location

URB. TURABO GARDENS CARR. #172 CAGUAS A CIDRA, CAGUAS, PR
(787) 743-3038

Quick Facts

NPI
1366256992
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile